Correlations of expressions of Toll-like receptor 4 and Janus kinase 3 in peripheral blood mononuclear cells with T helper 17 cell/regulatory T cell imbalance in patients with ankylosing spondylitis

1 Crossfield SSR, Marzo-Ortega H, Kingsbury SR, Pujades-Rodriguez M, Conaghan PG. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open. 2021;7(3):e001888. DOI: 10.1136/rmdopen-2021-001888 Search in Google Scholar

2 Xu H, Yu H, Liu L, Wu H, Zhang C, Cai W, et al. Integrative Single-Cell RNA-Seq and ATAC-Seq Analysis of Peripheral Mononuclear Cells in Patients With Ankylosing Spondylitis. Front Immunol. 2021;12:760381. DOI: 10.3389/fimmu.2021.760381 Search in Google Scholar

3 van der Heijde D, Braun J, Deodhar A, Baraliakos X, Landewé R, Richards HB, et al. Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology. 2019;58(3):388-400. DOI: 10.1093/rheumatology/key128 Search in Google Scholar

4 Wu J, Yan L, Chai K. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal. 2021;35(9):e23964. DOI: 10.1002/jcla.23964 Search in Google Scholar

5 Nash P, Kerschbaumer A, Dörner T, Dougados M, Fleischmann RM, Geissler K, et al. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Ann Rheum Dis. 2021;80(1):71-87. DOI: 10.1136/annrheumdis-2020-218398 Search in Google Scholar

6 Lee YH. Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Pharmacology. 2022;107(11-12):537-44. DOI: 10.1159/000525627 Search in Google Scholar

7 Ding MH, Xu PG, Wang Y, Ren BD, Zhang JL. Resveratrol Attenuates Ankylosing Spondylitis in Mice by Inhibiting the TLR4/NF-κB/NLRP3 Pathway and Regulating Gut Microbiota. Immunol Invest. 2023;52(2):194-209. DOI: 10.1080/08820139.2022.2154162 Search in Google Scholar

8 Xu WD, Liu SS, Pan HF, Ye DQ. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: a meta-analysis. Joint Bone Spine. 2012;79(6):566-9. DOI: 10.1016/j.jbspin.2012.02.012 Search in Google Scholar

9 Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34. DOI: 10.1136/ard-2022-223296 Search in Google Scholar

10 Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91. Search in Google Scholar

11 Tsur AM, David P, Watad A, Nissan D, Cohen AD, Amital H. Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study. J Gen Intern Med. 2022;37(13):3283-8. DOI: 10.1007/s11606-021-07241-2 Search in Google Scholar

12 Nancy Z, Yan L, Hui S, Paul B, Liye C. From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery. Front Immunol. 2021;12:624632. DOI: 10.3389/fimmu.2021.624632 Search in Google Scholar

13 Li Y, Huang L, Cai Z, Deng W, Wang P, Su H, et al. A Study of the Immunoregulatory Function of TLR3 and TLR4 on Mesenchymal Stem Cells in Ankylosing Spondylitis. Stem Cells Dev. 2019;28(20):1398-412. DOI: 10.1089/scd.2019.0039 Search in Google Scholar

14 Gupta L, Bhattacharya S, Agarwal V, Aggarwal A. Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease. Clin Rheumatol. 2016;35(12):3075-9. DOI: 10.1007/s10067-016-3448-x Search in Google Scholar

15 Olivera PA, Lasa JS, Bonovas S, Danese S, Peyrin-Biroulet L. Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis. Gastroenterology. 2020;158(6):1554-73.e12. DOI: 10.1053/j.gastro.2020.01.001 Search in Google Scholar

16 Liao H, Li T, Chen C. Jams kinase-1 and 3 in ankylosingspondyliis. J Farmos Med Assoc. 2019;118(1 Pt 1):134-41. DOI: 10.1016/j. jfma.2018.02.001 Search in Google Scholar

17 Facci L, Bolego C, Chemello C, Yasser R, Fusco M, Barbierato M, et al. 2-Pentadecyl-2-oxazoline inhibits lipopolysaccharide-induced microglia activation interfering with TLR4 signaling. Life Sci. 2023;335:122242. DOI: 10.1016/j.lfs.2023.122242 Search in Google Scholar

18 Zhang P, Yang M, Chen C, Liu L, Wei X, Zeng S. Toll-like receptor 4 (TLR4)/opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility. Front Immunol. 2020;11:1455. DOI: 10.3389/fimmu.2020.01455 Search in Google Scholar

19 McInnes IB, Szekanecz Z, McGonagle D, Maksymowych WP, Pfeil A, Lippe R, et al. A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. Rheumatology. 2022;61(5):1783-94. DOI: 10.1093/rheumatology/keab740 Search in Google Scholar

20 Xu F, Guanghao C, Liang Y, Jun W, Wei W, Baorong H. Treg-promoted New Bone Formation Through Suppressing TH17 by Secreting Interleukin-10 in Ankylosing Spondylitis. Spine. 2019;44(23):E1349-55. DOI: 10.1097/BRS.0000000000003169 Search in Google Scholar

21 Zeng J, Zhou R, Luo Z, Zhang N, Liu Z, Lin G. Clinical evidence of acupuncture and related therapy in patients with cancer-pain: A protocol for systematic review and meta-analysis. Medicine. 2020;99(45):e23119. DOI: 10.1097/MD.0000000000023119 Search in Google Scholar

22 Liao HT, Tsai CY. Cytokines and regulatory T cells in ankylosing spondylitis. Bone Joint Res. 2023;12(2):133-7. DOI: 10.1302/2046-3758.122.BJR-2022-0195.R1 Search in Google Scholar

23 Liu D, Liu B, Lin C, Gu J. Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis. Front Immunol. 2021;12:696973. DOI: 10.3389/fimmu.2021.696973 Search in Google Scholar

24 Fattahi MJ, Ahmadi H, Jafarnezhad-Ansariha F, Mortazavi-Jahromi SS, Rehm BHA, Cuzzocrea S, et al. Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis. Biomed Pharmacother. 2018;100:495-500. DOI: 10.1016/j.biopha.2018.02.059 Search in Google Scholar